As filed with the Securities and Exchange Commission on April 5, 2017
Registration No. 333-204520
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
OCEAN BIO-CHEM, INC.
(Exact name of Registrant as specified in its charter)
| Florida | 59-1564329 | |
| (State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
| 4041 SW 47 Avenue, Ft. Lauderdale, FL | 33314 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Ocean Bio-Chem, Inc., 2015 Equity Compensation Plan
(Full title of the plan)
Peter G. Dornau
Chairman of the Board, President and Chief Executive Officer
Ocean Bio-Chem, Inc.
4041 SW 47 Avenue
Ft. Lauderdale, FL 33314
954-587-6280
(Name, address and telephone number, including area code, of agent for service)
with a copy to:
Alan Singer
Morgan, Lewis & Bockius LLP
1701 Market Street
Philadelphia, PA 19103-2921
215-963-5000
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, filed by Ocean Bio-Chem., Inc. (the “Registrant”) with the Securities and Exchange Commission (the “Commission”), are hereby incorporated by reference:
| (a) | Annual Report on Form 10-K for the fiscal year ended December 31, 2016; |
| (b) | Current Report on Form 8-K filed on February 23, 2017, as amended by Form 8-K/A filed on February 24, 2017; |
| (b) | The description of the Registrant’s common stock set forth in its Registration Statement filed under the Securities Exchange Act of 1934, including any amendment or report filed for the purpose of updating such description. |
All documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 after the date of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates that all securities offered by this registration statement have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part of this registration statement from the date of filing of such document.
Any statement contained in a document incorporated or deemed to be incorporated by reference or deemed to be part of this registration statement will be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in this registration statement or in any other subsequently filed document that also is, or is deemed to be, incorporated by reference or deemed to be part of this registration statement modifies or replaces such statement. Any statement contained in a document that is deemed to be incorporated by reference or deemed to be part of this registration statement after the most recent effective date may modify or replace existing statements contained in this registration statement. Any such statement so modified or replaced shall not be deemed, except as so modified or replaced, to constitute a part of this registration statement.
Experts
The consolidated balance sheet of Ocean Bio-Chem, Inc. as of December 31, 2016, and the related consolidated statements of operations, shareholders’ equity, and cash flows for year ended December 31, 2016 have been audited by EisnerAmper LLP, independent registered public accounting firm, as stated in their report which is incorporated by reference. Such financial statements have been incorporated by reference in reliance on the report of such firm given upon their authority as experts in accounting and auditing.
In the event that EisnerAmper LLP consents to the incorporation by reference in this registration statement of its report relating to audited financial statements included in a document subsequently filed by the Registrant, such audited financial statements shall be incorporated herein in reliance upon such report of EisnerAmper LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
| 1 |
Item 8. Exhibits.
The file number for each of the Registrant’s filings with the Securities and Exchange Commission referenced below is 0-11102.
| Exhibit No. | Description | |
| *4.1.1 | Articles of Incorporation, as amended - incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2010. | |
| *4.1.2 | Articles of Amendment to the Articles of Incorporation, as filed on June 13, 2012 – incorporated by reference to Exhibit 3.1.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2012. | |
| *4.2 | Amended and Restated Bylaws - incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed on December 5, 2011. | |
| *5.1 | Opinion of Morgan, Lewis & Bockius LLP. | |
| 23.1 | Consent of EisnerAmper LLP. | |
| *23.2 | Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1). | |
| *24.1 | Power of Attorney (included on signature page of initial filing). | |
| *99.1 | Ocean Bio-Chem, Inc. 2015 Equity Compensation Plan. |
*Previously filed
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this post-effective amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ft. Lauderdale, State of Florida on April 5, 2017.
| OCEAN BIO-CHEM, INC. | ||
| By: | /s/ PETER G. DORNAU | |
| Peter G. Dornau | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, this post-effective amendment to the registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Capacity | Date | ||
/s/ JEFFREY S. BAROCAS |
Chief Financial Officer and Director | April 5, 2017 | ||
Jeffrey S. Barocas |
||||
| * | Director | April 5, 2017 | ||
| Diana Mazuelos Conard | ||||
| * | Director | April 5, 2017 | ||
| Gregor M. Dornau | ||||
| /s/ PETER G. DORNAU | Chief Executive Officer and Director | April 5, 2017 | ||
| Peter G. Dornau | ||||
| * | Director | April 5, 2017 | ||
| William W. Dudman | ||||
| Director | ||||
| Kimberly A. Krause | ||||
| * | Director | April 5, 2017 | ||
| James M. Kolisch | ||||
| * | Director | April 5, 2017 | ||
| John B. Turner | ||||
|
*By |
/s/ JEFFREY S. BAROCAS | |
| Jeffrey S. Barocas | ||
Attorney-in-Fact |
| 3 |
EXHIBIT INDEX
| Exhibit No. | Description | |
| *4.1.1 | Articles of Incorporation, as amended - incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2010. | |
| *4.1.2 | Articles of Amendment to the Articles of Incorporation, as filed on June 13, 2012 – incorporated by reference to Exhibit 3.1.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2012. | |
| *4.2 | Amended and Restated Bylaws - incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed on December 5, 2011. | |
| *5.1 | Opinion of Morgan, Lewis & Bockius LLP. | |
| 23.1 | Consent of EisnerAmper LLP. | |
| *23.2 | Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1). | |
| *24.1 | Power of Attorney (included on signature page of initial filing). | |
| *99.1 | Ocean Bio-Chem, Inc. Equity Compensation Plan. |
*Previously filed
4